Frontiers in oncology
Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections. See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.
Did you know?
Some hardships faced by frontier farmers were a lack of rainfall and dense earth that was difficult to plow, owing to the tough grasses of the Great Plains.Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ...Having a Frontier account is essential for managing your internet, TV, and phone services. It’s important to know how to login to your account so you can take advantage of all the ... Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). Sep 8, 2022 ... Welcome to this conference regarding cancer research and therapy organized by the Department of Oncology-Pathology.Figure 1 Hierarchical divisive clustering of brain tumor patients, based on the collected features. The dendrogram reporting the clusters identified through divisive hierarchical clustering is reported. Gower distance is reported on the y axis and each single unit analyzed (i.e. patients) on the x axis.4 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia 5 Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response remains limited.Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different disciplines.Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …Figure 1 Hierarchical divisive clustering of brain tumor patients, based on the collected features. The dendrogram reporting the clusters identified through divisive hierarchical clustering is reported. Gower distance is reported on the y axis and each single unit analyzed (i.e. patients) on the x axis.Optimizing the first-line treatment for metastatic colorectal cancer. The prognosis of metastatic CRC (mCRC) patients has significantly improved in the past 20 years thanks to the introduction of novel therapeutic approaches, including surgery of liver, lung and peritoneal metastases, and of more effective anticancer drugs and combinatory ...3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Given the effective heating ability to moderate temperatures, the improved tumor perfusion, and ability to increase drug absorption, mEHT is a safe and ...» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,416The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and ...Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center.The objective of the Skin Cancer section is to expand our understanding of molecular and cellular mechanisms involved in skin cancer progression. Moreover, the section is dedicated to the publication of high-quality clinical, translational research as well as bioinformatics studies in a timely manner. We are especially interested in receiving ...Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Jürgen Schlegel. Ekkehard Hewer. Bianca Pollo. Theoni Maragkou. Frontiers in Oncology. doi 10.3389/fonc.2024.1389608. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.The core function of a multidisciplinary team (MDT) is to bring together a group of healthcare professionals from different fields in order to determine patients' treatment plan. Most of head and neck cancer (HNC) units are currently led by MDTs that at least include ENT and maxillofacial surgeons, radiation and medical oncologists.4 days ago · timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology. Frontiers in Oncology publishes rigorously peer-reviewed rThe objective of the Skin Cancer section The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ... Editorial: Novel targets for ovarian cancer stem cells. Although ovar Since then, the development of ICIs represents a paradigm shift in oncology therapy and prompted us to further study the role of ICIs in treatment of patients with BM. The Checkmate 204 trial of dual ICI therapy showed a dramatic intracranial response rate of 57% of BM from melanoma ( 10 ), as did the randomized phase II ABC … May 8, 2024 · Yutaka Tamura. Kengo Yoshii. To
Feb 1, 2024 ... The upcoming scientific Forum titled "New Frontiers in Cancer and Healthy Aging," organized by IBSA Foundation for Scientific Research in ...See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.List of posts by tag Frontiers in OncologyThe Cardio-Oncology section of Frontiers in Cardiovascular Medicine is to provide a prime publication platform for this emerging field in medicine. It should speak to clinicians and researchers across the multiple diciplines that contribute to this field, including cardiology, oncology, hematology, radiation oncology, surgery, internal medicine, pediatrics, …
Explore the impact and performance of Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the number of citations, articles, views, …The best modem for Frontier DSL is the Actiontec 300 Mbps, a Frontier-compatible modem with rating of four out of five stars on Amazon.com. Other Frontier-compatible modems include...Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. The Pediatric Oncology section of Frontiers in Oncology aims to provid. Possible cause: priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United State.
timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.The International Cardio-Oncology Society registry shows 21 countries with national cardio-oncology programs, and 81% of centers are in upper-middle to high-income countries . A study of oncologists in the central US showed 67.5% practiced in exclusively urban locations, 11.3% in exclusively rural locations, and 21.1% in both rural and urban …Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.
Research Topics. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells.Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024, About.
brian jensen. School of Medicine, University of North Carolina at C Mechanobiology in oncology: basic concepts and clinical prospects. Michelle B. Chen 1† Yousef Javanmardi 2† Somayeh Shahreza 2 Bianca Serwinski 2,3,4 Amir Aref 5 Boris Djordjevic 2,3 Emad Moeendarbary 1,2 *. 1 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States. Survival of 48866 cancer patients: results from Nantong area, China. Table 1: Frontiers' APCs are structu Oct 22, 2023 ... Results from the ongoing phase Ib/II BEGONIA platform trial support the promise of the anti-TROP2 ADC datopotamab deruxtecan in combination with ...A recent retrospective analysis on 152 advanced OSCC patients examined the outcome of cancer therapy and the incidence of tumor recurrence after PBM (660 nm, 40 mW, 10 J/cm 2) for the prevention of OM. Results showed that prophylactic PBM did not influence treatment outcome of primary cancer, recurrence, the development of new primary tumors ... 1 Introduction. Immune checkpoint molecules play a Given the effective heating ability to moderate temperatures, the improved tumor perfusion, and ability to increase drug absorption, mEHT is a safe and ...The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ... Aims and scope. Frontiers in Oncology is Effect of different treatment modalities on Preprint repository name [Preprint] (2008). Availabl Nevertheless, according to the Associazione Italiana di Oncologia Medica (AIOM), the European Society for Medical Oncology (ESMO), and the National Comprehensive Cancer Network ® (NCCN) guidelines, neoadjuvant chemotherapy is an established treatment that improves oncological outcomes in locally advanced … michael kattan. Cleveland Clinic Lerner College of Medicine Aram Boada. Anna Martinez-Cardús. Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression. Frontiers in Immuno-Oncology. Print Special Issue Flyer. SPCNSTCL with isolated brain involvement occu 3 days ago · bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.